In the lush forests of Oahu and the sprawling apiaries of the Big Island, a high-stakes evolutionary drama has been unfolding for 17 years. While it may look like paradise, for the honey bee, Hawaii has become a rigorous testing ground—one that might just hold the key to saving the species worldwide.

New research published in Trends in Parasitology shows how Hawaii has acted as a living laboratory, allowing scientists to witness a complete evolutionary cycle that has taken decades to play out elsewhere. Led by an international team including Declan Schroeder, professor at the University of Minnesota College of Veterinary Medicine (CVM), and CVM postdoctoral researcher Clarissa Pellegrini Ferreira, the study offers a definitive start-to-finish look at how bees, mites, and viruses adapt to one another in real-time. What they found could reshape how we protect pollinators across the globe.

The stakes of this drama are nothing short of existential for the hive. The crisis begins with the Varroa destructor mite, a parasite that feeds on a bee’s fat body tissue—essential for energy storage and immune function. But the mite’s most lethal role is as a living needle; as it feeds, it injects a virus called deformed wing virus (DWV) directly into the bee's circulatory system. This one-two punch is the primary driver of colony collapse: infected bees can on occasion be born with shriveled wings, but even seemingly healthy bees can show cognitive impairments that leave them unable to forage or care for the brood. When enough individuals fail, the hive’s social structure shatters, and the entire colony—tens of thousands of bees—can perish in weeks.

A 17-year story arc

For most of the world, the arrival of the Varroa destructor mite happened so long ago that scientists missed the beginning of the story. But in Hawaii, the clock only started ticking 17 years ago. Because the islands are geographically isolated, researchers were able to track exactly when the mites arrived and watch as the entire ecosystem reacted.

"In this one location, we basically see evidence of everything we have gleaned from different places around the world, and it’s all sitting in Hawaii," says Schroeder. "No other site offers us this comprehensive understanding from start to finish."

The molecular research team, led by Schroeder and long-term collaborator entomologist Stephen Martin from the University of Salford, began their work in Hawaii soon after the mite was first detected on Oahu in 2007. For nearly two decades, with assistance from Ethel Villalobos, a honey bee biologist in Hawaii, they have monitored the transition from a mite-free environment to an infested one. This long-term presence allowed them to document the viral landscape before and after the mites arrived—a rare scientific baseline that does not exist for the U.S. mainland or Europe.

The viral plot twist

While the mites are the visible enemy, the real killer is the virus they carry. Schroeder’s previous research famously proved that the mites act as a sort of selective filter, shuffling around diverse, harmless virus variants and leaving behind only the most adaptive and sometimes lethal strains. He has spent decades characterizing this shift, identifying the move from the original virulent Type A DWV to a more Varroa-adapted and highly contagious Type B. His work proved that Type B is actively outcompeting other variants globally.

Schroeder and Ferreira’s recent study marks the first time that new recombinants, or chimera variants made up of both type A and B genomes, have been reported in Hawaii, confirming a global trend where DWV is evolving just as fast as the bees. These chimeras appear independently of each other, bearing the fitness traits that undermine the health of honey bees. “Different variants lead to different health outcomes, and some are more pathogenic than others,” notes Schroeder. “Consequently, colony losses will continue to be unpredictable and devastating.”

Two tales of survival

The study highlights a fascinating split in how bees are surviving this Varroa invasion. In the forests of Oahu, free-living (feral) bees were left to face the mites without human help. After initial devastating losses, eventually they thrived—likely because they evolved a behavior known as recapping. Worker bees sense an infected cell, open it to remove the mite, and reseal it, effectively stopping the parasite in its tracks by disrupting their delicate reproductive cycle. The team hypothesizes that by repeatedly disturbing the brood cells, the bees lower the mites’ birth rates just enough to keep the viral levels in the hive below the tipping point that causes a total colony collapse.

On the Big Island, however, as in many other parts of the globe, beekeepers have relied on miticides to kill the parasites. This has created a spiraling cycle of intervention: as beekeepers use chemicals to kill the mites, the mites eventually  evolve resistance, forcing humans to use stronger or more frequent treatments just to prevent total colony loss. Because this chemical shield keeps the bees alive artificially, it prevents the colonies from ever evolving their own natural defenses. And meanwhile, the viral threat continues to innovate, evolving into even more adapted chimera variants that can bypass these traditional defenses.

Rewriting the ending

The research from Schroeder and Ferreira suggests that the approach to protecting bees—focusing solely on killing mites with chemicals—may be a losing battle. Nor is “letting nature take its course” an option, given the increasing virulence of the new forms of the virus. Instead, the focus must shift towards combating the viruses themselves.

"We have to accept that [the mite] is a mixing vessel for viruses," Schroeder says. "We need to start intervening in the virology piece of this."

Oahu’s wild bees demonstrate that a mite-infected system can stabilize through natural selection. However, managed colonies can’t afford to weather the mass die-offs required for natural resistance to emerge. Instead, researchers are looking toward a new kind of active intervention: antivirals. By treating the virus directly within the hive, scientists hope to provide managed bees with the health and stability found in the wild, without catastrophic losses. And  because Hawaii is a closed system, it offers a safe place to test the next generation of honey bee medicine. “Ultimately, we need to take a One Health approach,” says Schroeder. “Without treating the whole biological system we will continue to fall short”.

The Hawaiian archipelago has shown us the story arc of a crisis. Now, thanks to the work of CVM researchers and their collaborators, we may finally have the ideal study site to write a better ending for honey bees everywhere.